LANGER SUSAN 4

What Happened
Susan Langer, a director of Biogen Inc. (BIIB), received an award of 1,505 restricted stock units (RSUs) on June 9, 2026. The filing shows an acquisition at $0.00 (award/grant), i.e., no cash was paid by the insider. The filing does not state a dollar value based on market price.

Key Details

• Transaction date: 2026-06-09 (Form 4 filed 2026-06-11; appears to be filed within the two-business-day reporting window).
• Transaction type/code: Award/Grant (A).
• Shares/units awarded: 1,505 restricted stock units. Price paid: $0.00.
• Shares owned after transaction: Not specified in the excerpt provided.
• Vesting note: RSUs vest on the earlier of (i) the next annual meeting or (ii) the one-year anniversary of the grant date (June 9, 2027). (From filing footnote.)

Context
RSU grants are a common form of director/employee compensation and represent a claim to company shares that will convert upon vesting; they do not necessarily signal immediate insider buying or selling intent. Because these units vest over time (or at the next annual meeting), they subject the insider to future holding/vesting conditions rather than an immediate market transaction.